AI
QNCX icon

Alphabet Inc’s Quince Therapeutics QNCX Stock Holding History

Alphabet Inc’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-946
Closed -$634K – 30
2025
Q4 		$634K Hold
946
– – 0.02% 27
2025
Q3 		$308K Hold
946
– – 0.01% 35
2025
Q2 		$312K Hold
946
– – 0.01% 33
2025
Q1 		$252K Hold
946
– – 0.02% 37
2024
Q4 		$354K Hold
946
– – 0.02% 35
2024
Q3 		$148K Hold
946
– – 0.01% 38
2024
Q2 		$142K Hold
946
– – 0.01% 38
2024
Q1 		$200K Hold
946
– – 0.01% 38
2023
Q4 		$199K Hold
946
– – 0.01% 39
2023
Q3 		$212K Hold
946
– – 0.01% 39
2023
Q2 		$286K Hold
946
– – 0.02% 41
2023
Q1 		$295K Hold
946
– – 0.02% 44
2022
Q4 		$121K Hold
946
– – 0.01% 49
2022
Q3 		$252K Hold
946
– – 0.01% 47
2022
Q2 		$420K Hold
946
– – 0.02% 52
2022
Q1 		$1.17M Hold
946
– – 0.04% 51
2021
Q4 		$2.39M Hold
946
– – 0.06% 48
2021
Q3 		$17.3M Hold
946
– – 0.41% 24
2021
Q2 		$10M Hold
946
– – 0.2% 27
2021
Q1 		$6.81M Hold
946
– – 0.27% 25
2020
Q4 		$5.25M Hold
946
– – 0.25% 28
2020
Q3 		$9.46M Hold
946
– – 0.44% 14
2020
Q2 		$8.76M Hold
946
– – 0.4% 16
2020
Q1 		$8.63M Hold
946
– – 0.57% 15
2019
Q4 		$10.6M Sell
946
-615
-39% -$3.71M 0.64% 14
2019
Q3 		$7.78M Sell
1,561
-708
-31% -$4.36M 0.23% 16
2019
Q2 		$19.3M Buy
+2,269
New +$13.6M 0.37% 9

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Alphabet Inc's QNCX Position: Q1 2026 in Review

Alphabet Inc sold out of Quince Therapeutics (QNCX) in Q1 2026, closing a stake of 946 shares — an estimated $634K sold.

Alphabet Inc first reported a position in QNCX in Q2 2019 and held it in 27 quarters. The position peaked at $19.3M in Q2 2019. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Alphabet Inc reported no remaining Quince Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Alphabet Inc sold 946 Quince Therapeutics shares in Q1 2026, an estimated $634K.
  • Alphabet Inc first reported a position in Quince Therapeutics in Q2 2019 and held it in 27 quarters.
  • Alphabet Inc's Quince Therapeutics position peaked at $19.3M in Q2 2019.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Alphabet Inc's 13F filing for Q1 2026, filed 8 May 2026.